News
Trump tells DOL to develop PBM transparency regulations to lower drug prices
By Allison BellThe new executive order requires the department to come up with a proposal within 180 days.
Trending Stories
3
Market Insights
Gen X turns 60: Are these employees ready for retirement?
6
Slideshow
5 top states where people have arthritis
Benefits & Health Care
Recommended For You
Recent Stories
4
Market Insights
80% of workers say CEOs are overpaid in widening income divide
Regulation & Compliance
Our Writers
Special Reports
![]()
Biden's pharma fix: New 'march-in' rule allows HHS to seize patents of pricey drugs
Pres. Biden's administration on Thursday unveiled a new framework allowing authorities the right to seize certain drug patents and license them to other manufacturers in order to lower drug prices.
BrowseMore Coverage
Featured Event
May 06, 2025 Boston
BenefitsPRO Broker Expo 2025
The premier educational and networking event for employee benefits brokers and agents.
View Event Details
Webcasts
Understanding Subrogation: Best Practices for Benefits Advisors and TPAs
Sponsored by Intellivo Watch NowAlternative Health Plan Designs: Key to Keeping Employers in the Market?
Sponsored by Claritev Watch NowPodcasts
